首页 | 本学科首页   官方微博 | 高级检索  
检索        


Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation
Authors:Peter J Darlington PhD  Tarik Touil PhD  Jean‐Sebastien Doucet BSc  Denis Gaucher PhD  Joumana Zeidan PhD  Dominique Gauchat PhD  Rachel Corsini MSc  Ho Jin Kim MD  Martin Duddy MD  Farzaneh Jalili BSc  Nathalie Arbour PhD  Hania Kebir PhD  Jacqueline Chen PhD  Douglas L Arnold MD  Marjorie Bowman BScN  Jack Antel MD  Alexandre Prat MD  PhD  Mark S Freedman MD  Harold Atkins MD  Rafick Sekaly PhD  Remi Cheynier PhD  Amit Bar‐Or MD  for the Canadian MS/BMT Study Group
Institution:1. Neuroimmunology Unit, Montreal Neurological Institute, McGill University, , Montreal, Quebec, Canada;2. Laboratory of Immunology, University of Montreal Hospital Research Centre, , Quebec, Canada;3. Department of Medicine, University of Montreal Hospital Research Center–Notre Dame Hospital, , Montreal, Quebec, Canada;4. Neuroimmunology Unit, University of Montreal Hospital Center–Notre Dame Hospital, , Montreal, Quebec, Canada;5. McConnell Brain Imaging Center, , Montreal, Quebec, Canada;6. Neurology Department, Ottawa General Hospital, , Ottawa, Ontario, Canada;7. Ottawa Hospital Blood and Marrow Transplant Program, University of Ottawa, , Ottawa, Ontario, Canada;8. Inserm, U1016, Institut Cochin, , Paris, France;9. CNRS, UMR8104, , Paris, France;10. Université Paris Descartes, Sorbonne Paris Cité, , France;11. Experimental Therapeutics Program, , Montreal, Quebec, Canada
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号